These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31611628)

  • 1. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
    Alanazi B; Munje CR; Rastogi N; Williamson AJK; Taylor S; Hole PS; Hodges M; Doyle M; Baker S; Gilkes AF; Knapper S; Pierce A; Whetton AD; Darley RL; Tonks A
    Leukemia; 2020 Feb; 34(2):427-440. PubMed ID: 31611628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
    Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
    Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression.
    Yao CY; Lin CC; Wang YH; Hsu CL; Kao CJ; Hou HA; Chou WC; Tien HF
    J Formos Med Assoc; 2023 Jul; 122(7):636-647. PubMed ID: 36428148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
    de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
    Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
    Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.
    Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR
    PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia.
    Nakamura S; Nagata Y; Tan L; Takemura T; Shibata K; Fujie M; Fujisawa S; Tanaka Y; Toda M; Makita R; Tsunekawa K; Yamada M; Yamaoka M; Yamashita J; Ohnishi K; Yamashita M
    PLoS One; 2011; 6(11):e28011. PubMed ID: 22132193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells.
    Xia L; Liu JY; Yang MY; Zhang XH; Jiang Y; Yin QQ; Luo CH; Liu HC; Kang ZJ; Zhang CT; Gao BB; Zhou AW; Cai HY; Waller EK; Yan JS; Lu Y
    Cancer Res; 2024 Feb; 84(3):479-492. PubMed ID: 38095536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
    Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.
    Yang XY; Jin J; Huang J; Li P; Xue JW; Wu XJ; He ZX
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7324-7334. PubMed ID: 32706071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
    Strassberger V; Gutbrodt KL; Krall N; Roesli C; Takizawa H; Manz MG; Fugmann T; Neri D
    J Proteomics; 2014 Mar; 99():138-51. PubMed ID: 24487095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells.
    Long B; Wang LX; Zheng FM; Lai SP; Xu DR; Hu Y; Lin DJ; Zhang XZ; Dong L; Long ZJ; Tong XZ; Liu Q
    Cell Physiol Biochem; 2016; 38(4):1288-302. PubMed ID: 27008269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia.
    Juncà J; Garcia O; Garcia-Caro M; Vila J; Zamora L; Cabezón M; Alonso E; de la Banda E; Rodríguez-Hernández I; Ribera JM; Millá F
    Ann Hematol; 2016 Dec; 95(12):1949-1954. PubMed ID: 27595757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia.
    Wang N; Guo D; Zhao YY; Dong CY; Liu XY; Yang BX; Wang SW; Wang L; Liu QG; Ren Q; Lin YM; Ma XT
    Oncotarget; 2015 Aug; 6(25):20977-92. PubMed ID: 26023795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.